Bio-Path Holdings, Inc.
BPTH· OTC
Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001558370-22-013644
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$3.01M | -$1.81M | -$2.04M | -$2.46M |
| EPS Diluted | -$0.42 | -$0.26 | -$0.55 | -$0.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end